6 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18504781 | Composition Comprising Antisense Oligonucleotide and Use Thereof for Treatment of Duchenne Muscular Dystrophy | ARIETI, RUTH SOPHIA | 1635 | Final Rejection | Nov 08, 2023 |
| 18288057 | METHOD FOR PRODUCING OLIGONUCLEIC ACID COMPOUND | GALSTER, SAMUEL LEONARD | 1693 | Non-Final OA | Oct 24, 2023 |
| 18284941 | THERAPEUTIC AGENT FOR GAIT DISTURBANCE | MCMILLIAN, KARA RENITA | 1623 | Non-Final OA | Sep 29, 2023 |
| 17788551 | ANTITUMOR DRUG FOR USE IN COMBINATION WITH IMMUNE CHECKPOINT INHIBITOR | RZECZYCKI, PHILLIP MATTHEW | 1625 | Final Rejection | Jun 23, 2022 |
| 17418203 | METHOD FOR INDUCING MUSCULAR CELLS USING CELLS IN SPOT URINE | REGLAS, GILLIAN CHELSEA | 1632 | Final Rejection | Jun 24, 2021 |
| 17293929 | 1,3,4-OXADIAZOLONE COMPOUND AND PHARMACEUTICAL | ELENISTE, PIERRE PAUL | 1622 | Non-Final OA | May 14, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial